Brief: Sutro Biopharma Q1 Revenue USD 14.523 Million Vs. IBES Estimate USD 8.08 Million
14/05/2026 21:05
May 14 (Reuters) - Sutro Biopharma Q1 operating expenses USD 44.179 million. Q1 operating income USD -29.656 million Q1 net income USD -38.484 million
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates